$40,000 of ANHEUSER-BUSCH COMPANIES lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"IP infringement and rule-of-law issues in Mexico."
You can find more data on corporate lobbying on Quiver Quantitative.
BUD Congressional Stock Trading
Members of Congress have traded $BUD stock 5 times in the past 6 months. Of those trades, 2 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $BUD stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 4 times. They made 2 purchases worth up to $30,000 on 07/16, 06/09 and 2 sales worth up to $30,000 on 08/04, 06/11.
- REPRESENTATIVE BRUCE WESTERMAN sold up to $15,000 on 04/21.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
BUD Hedge Fund Activity
We have seen 246 institutional investors add shares of BUD stock to their portfolio, and 282 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 5,405,244 shares (+348.6%) to their portfolio in Q2 2025, for an estimated $371,448,367
- DODGE & COX removed 2,638,596 shares (-6.4%) from their portfolio in Q2 2025, for an estimated $181,324,317
- ROYAL BANK OF CANADA removed 1,920,047 shares (-48.6%) from their portfolio in Q2 2025, for an estimated $131,945,629
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC removed 1,559,800 shares (-55.9%) from their portfolio in Q2 2025, for an estimated $107,189,456
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 1,361,743 shares (-74.9%) from their portfolio in Q2 2025, for an estimated $93,578,978
- ARMISTICE CAPITAL, LLC removed 1,359,000 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $83,660,040
- RIVULET CAPITAL, LLC removed 1,115,250 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $68,654,790
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
BUD Analyst Ratings
Wall Street analysts have issued reports on $BUD in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Goldman Sachs issued a "Buy" rating on 05/12/2025
To track analyst ratings and price targets for BUD, check out Quiver Quantitative's $BUD forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
